1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 06 JULY 2015

CNS Drug News 06 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Avanir's Inhaled Migraine Treatment Will Beat Allergan's To Market
Industry Brief - Cynapsus Enrols First Patient In Pivotal Phase III Study Of Sublingual Apomorphine
Industry Brief - Pharma Two B's P2B001 Phase IIb Study For Early Stage PD Sees Positive Results
Industry Trend Analysis - Big Pharma Investment In Alzheimer's To Continue Despite Sembragiline's Failure
Industry Brief - ELND005 Phase II/III Study Misses Primary Efficacy Endpoint
Industry Brief - CereSpir Submits SPA Request For CSP-1103 Phase III Trial In MCI Due To AD
Industry Trend Analysis - Genentech's Ocrelizumab Will Be Used In Second-Line MS
Industry Brief - Teva/Active Biotech Report Completion Of Patient Enrolment In Laquinimod Phase III Trial
Industry Brief - Vaccinex Initiates VX15 Phase II Trial In HD
Industry Brief - MTP Receives Approval For Additional Radicut Indication In Japan
Industry Brief - BioBlast's Cabaletta Receives EC ODD For SCA
Industry Brief - Avanir Reports Positive Top-Line Results From Stroke/TBI Cohorts Of PRISM II Study
Industry Brief - VistaGen Receives Clearance To Initiate NIH-Funded Phase II Study In MDD
Industry Brief - Companies Gain US Desvenlafaxine Approval
Industry Brief - FDA Extends Review Period For Cariprazine To September
Industry Brief - Positive REPRIEVE Study Results Demonstrate Long-Term Maintenance Effects Of Fanapt
Industry Brief - Invega Trinza Available In US
Industry Brief - Young Adults With Schizophrenia Show Improved Functioning/HRQoL With Abilify Maintena
Industry Brief - Egalet Reports Positive Results From Intranasal HAL Study Of Abuse-Deterrent Morphine
Industry Brief - Eisai's Fycompa Gains EC Marketing Authorisation For PGTC Seizures
Industry Brief - UCB Submits Lacosamide In Japan For Epilepsy
Industry Brief - Phase III Study Of Single-Dose Emend For Injection Regimen Meets Primary Endpoint
Industry Brief - Newron's Sarizotan Receives Positive COMP Opinion For Rett Syndrome
Industry Brief - Biogen Plans New Production Plant In Switzerland

Table Of Contents

CNS Drug News 06 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.